Home » Elan Receives First Japanese Product Approval Using NanoCrystal Technology
Elan Receives First Japanese Product Approval Using NanoCrystal Technology
Elan Drug Technologies, a business unit of Elan Corporation,
plc announces the approval by the Japanese Ministry of Health, Labour and Welfare of EMEND (aprepitant) for the treatment of cancer chemotherapy-induced
nausea and vomiting.
Benzinga
Benzinga
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May